IceCure receives U.S. patent allowance for next-gen XSense cryoprobes; stock climbs
Source: SeekingAlpha
2025-09-18 08:52:09 ET
More on IceCure Medical
- IceCure Medical Ltd (ICCM) Q2 2025 Earnings Call Transcript
- IceCure Medical GAAP EPS of $0.12, revenue of $1.25M
- Seeking Alpha’s Quant Rating on IceCure Medical
- Historical earnings data for IceCure Medical
- Financial information for IceCure Medical
Read the full article on Seeking Alpha
For further details see:
IceCure receives U.S. patent allowance for next-gen XSense cryoprobes; stock climbs
IceCure Medical Ltd.
NASDAQ: ICCM
ICCM Trading
0.03% G/L:
$0.6141 Last:
21,662 Volume:
$0.62 Open:
ICCM Latest News
March 10, 2026 08:30:00 am
IceCure Medical to Report 2025 Full Year Financial and Operating Results on March 17, 2026
March 09, 2026 08:30:00 am
American Society of Breast Surgeons (ASBrS) Resource Guide Update Recommends Cryoablation for Low-Risk Breast Cancer
ICCM Stock Data
$41,357,048
35,998,493
N/A
10
N/A
Medical Equipment & Supplies
Healthcare
IL
Caesarea
